US41358P2056 - Common Stock
HARPOON THERAPEUTICS INC
NASDAQ:HARP (3/8/2024, 7:11:33 PM)
After market: 23 -0.01 (-0.04%)23.01
+0.02 (+0.09%)
Harpoon Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in South San Francisco, California and currently employs 53 full-time employees. The company went IPO on 2019-02-08. Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company. The firm is engaged in the developing a T cell engager that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient’s own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells. The firm is developing a pipeline of T cell engagers using its TriTACs technology, focused on the treatment of solid tumors and hematologic malignancies. The company has also nominated its clinical candidate using its ProTriTAC platform, a prodrug version of its TriTAC platform, designed to expand the target space for T cell engagers and bring the benefits of TriTACs to the patients. The Company’s TriTAC product candidates include HPN217, and HPN328. The Company’s ProTriTAC product candidate include HPN601, which is being developed for the treatment of multiple solid tumor indications.
HARPOON THERAPEUTICS INC
611 Gateway Boulevard, Suite 400
South San Francisco CALIFORNIA 94080
P: 16504437400
CEO: Gerald McMahon
Employees: 53
Website: https://www.harpoontx.com/
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
It's buying a company with sophisticated biotechnology platforms that could drive lots of growth -- eventually.
These are the best dividend growth stocks to buy as they represent companies with healthy free cash flow upside visibility.
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Here you can normally see the latest stock twits on HARP, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: